Fresenius Kabi launches small-volume prefilled heparin sodium syringes
Fresenius Kabi is offering preservative-free heparin sodium injection, in 5,000 units per 0.5 mL in Simplist ready-to-administer prefilled syringes.
“Fresenius Kabi is focused on expanding our Heparin and Simplist prefilled syringe portfolios with this Simplist Heparin prefilled syringe,” Fresnius Kabi USA president and CEO John Ducker said. “By combining a small-volume presentation of Heparin with our other convenient ready-to-administer prefilled syringes, this product will support safe practices for this high-alert Medication.”
Fresenius Kabi also offers heparin sodium injection, 5,000 units per 1 mL in a Simplist prefilled syringe along with Heparin Sodium in five freeflex premix ready-to-administer containers and 11 vial presentations.
Heparin Sodium is an anticoagulant indicated for: prophylaxis and treatment of venous thromboembolism and pulmonary embolism; prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism; and use as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures.